<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03462082</url>
  </required_header>
  <id_info>
    <org_study_id>17-5785</org_study_id>
    <nct_id>NCT03462082</nct_id>
  </id_info>
  <brief_title>Asymmetric Subthalamic Deep Brain Stimulation for Axial Motor Dysfunction in Parkinson's Disease</brief_title>
  <official_title>A Single-center, Randomized, Double-blinded, Double-crossover Trial of Asymmetric Subthalamic Deep Brain Stimulation for Axial Motor Dysfunction in Parkinson's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Toronto</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This single-center, randomized, double-blinded, double-crossover comparative efficacy trial
      will study the effects of unilateral 50% voltage reduction in axial motor dysfunction for
      patients with Parkinson's disease that develop treatment-resistant postural stability gait
      dysfunction after bilateral subthalamic nucleus deep brain stimulation surgery.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 22, 2018</start_date>
  <completion_date type="Anticipated">June 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Gait velocity</measure>
    <time_frame>Four weeks after each study arm</time_frame>
    <description>Gait velocity measured during the 10-meter walk test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postural instability gait dysfunction 1</measure>
    <time_frame>Four weeks after each study arm</time_frame>
    <description>Measured by the mini-BESTest</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postural instability gait dysfunction 2</measure>
    <time_frame>Baseline and four weeks after each of the 3 study arms</time_frame>
    <description>Measured by the UPDRS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postural instability gait dysfunction 3</measure>
    <time_frame>Baseline and four weeks after each of the 3 study arms</time_frame>
    <description>Quantitatively measured by the Zeno walkway</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Freezing of gait</measure>
    <time_frame>Baseline and four weeks after each of the 3 study arms</time_frame>
    <description>Measured by the freezing of gait questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Speech dysfunction</measure>
    <time_frame>Baseline and four weeks after each of the 3 study arms</time_frame>
    <description>Measured by the Praat software</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MDS-UPDRS</measure>
    <time_frame>Baseline and four weeks after each of the 3 study arms</time_frame>
    <description>Total and motor scores</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Select cognitive tasks</measure>
    <time_frame>Baseline and four weeks after each of the 3 study arms</time_frame>
    <description>Sensitive for brain hemispheric lateralization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>Baseline and four weeks after each of the 3 study arms</time_frame>
    <description>Measured by the 39-item Parkinson's disease questionnaire</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">27</enrollment>
  <condition>Parkinson Disease</condition>
  <arm_group>
    <arm_group_label>Baseline STN-DBS</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Maintenance of baseline bilateral STN-DBS settings.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Asymmetric STN-DBS 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Unilateral 50% reduction of voltage (e.g. right side)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Asymmetric STN-DBS 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Unilateral 50% reduction of voltage (e.g. left side)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Asymmetric STN-DBS</intervention_name>
    <description>Asymmetric deep brain stimulation</description>
    <arm_group_label>Asymmetric STN-DBS 1</arm_group_label>
    <arm_group_label>Asymmetric STN-DBS 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with Parkinson's disease (PD) (previously diagnosed according to the UK brain
             bank criteria) who develop treatment-resistant postural instability gait dysfunction
             (PIGD) more than 6 months but less than 5 years after bilateral subthalamic nucleus
             deep brain stimulation (STN-DBS).

          -  Treatment-resistant PIGD will be defined as freezing of gait and UPDRS or MDS-UPDRS
             PIGD subscales of more than 6 points despite optimization of medications and bilateral
             STN-DBS programming.

        Exclusion Criteria:

          -  Treatment-resistant PIGD less than 6 months or more than 5 years after STN-DBS
             surgery.

          -  PIGD responsive to optimization of medications and/or bilateral STN-DBS programming.

          -  Cognitive impairment or psychiatric comorbidities (including substance abuse) that
             would interfere with the informed consent process, study adherence or outcome
             assessments.

          -  Advanced PD or any other neurological, cardiovascular or musculoskeletal
             co-morbidities that would preclude or require assistance to complete the 10-meter
             walking test.

          -  Patients not able to comply with 4-week interval evaluations following their potential
             enrollment due to personal reasons.

          -  Serious illness (requiring systemic treatment and/or hospitalization) until subject
             either completes therapy or is clinically-stable on therapy, in the opinion of the
             site investigator, for at least 30 days prior to study entry.

          -  Inability or unwillingness of subject or legal guardian/representative to give written
             informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alfonso Fasano, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Toronto</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alfonso Fasano, MD, PhD</last_name>
    <phone>+1 416 603 5800</phone>
    <phone_ext>5961</phone_ext>
    <email>alfonso.fasano@uhn.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Karlo J Lizarraga, MD, MS</last_name>
    <phone>+1 416 603 5800</phone>
    <phone_ext>5990</phone_ext>
    <email>karlo.lizarraga@uhnresearch.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Movement disorders Centre, Toronto Western Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5T 2S8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alfonso Fasano, MD, PhD</last_name>
      <phone>+1 416 603 5800</phone>
      <phone_ext>5961</phone_ext>
      <email>alfonso.fasano@uhn.ca</email>
    </contact>
    <contact_backup>
      <last_name>Karlo J Lizarraga, MD, MS</last_name>
      <phone>+1 416 603 5800</phone>
      <phone_ext>5990 / 2309</phone_ext>
      <email>karlo.lizarraga@uhnresearch.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Karlo J Lizarraga, MD, MS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 5, 2018</study_first_submitted>
  <study_first_submitted_qc>March 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 12, 2018</study_first_posted>
  <last_update_submitted>March 11, 2018</last_update_submitted>
  <last_update_submitted_qc>March 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Toronto</investigator_affiliation>
    <investigator_full_name>Alfonso Fasano</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Parkinson's disease</keyword>
  <keyword>axial motor dysfunction</keyword>
  <keyword>asymmetric neuromodulation</keyword>
  <keyword>subthalamic nucleus deep brain stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

